News aXichem AB

Stocks

AXIC A

SE0005250719

Specialty Chemicals

Market Closed - Nasdaq Stockholm 09:30:00 15/09/2026 pm IST			5-day change	1st Jan Change
1.725 ^SEK	-6.25%		-5.74%	-16.67%

27/08	AXichem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
26/08	Calendar Thursday, August 27	FW

All News

Mentions Relevance

08/09	AXichem : notes growing commercial adoption in Brazil for aXiphen ruminant as Garra Nutrição increases volume to four tonnes	PU
27/08	AXichem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
24/08	AXichem : CEO Torsten Helsing Presents the Report for the Second Quarter 2026 in a Live Web Conference	PU
24/08	AXichem : CEO Torsten Helsing Presents the Report for the Second Quarter 2026 in a Live Web Conference	PU
24/07	AXichem's Salmonella-inhibiting Chicken Feed Additive Gets EU Agency Backing	MT
24/07	AXichem : receives positive scientific opinion from EFSA for phenylcapsaicin as a salmonella-inhibiting additive in chicken feed	PU
26/06	AXichem Receives Order for Feed Additives for SEK4.2 Million	MT
26/06	AXichem : receives order for aXiphen from Chr. Olesen in Brazil to a value of SEK 4.2 million, for use in feed for chickens and ruminants	PU
17/06	Axichem AB Elects Michael Engstrom As Chairman Of The Board	RE
21/05	Axichem Q1 operating loss narrows to SEK 2.8 mln	RE
21/05	AXichem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
15/05	Axichem proposes chairman	RE
07/05	Axichem launches axiphen ruminant in Brazil	RE
09/04	AXichem: Final study report shows aXiphen improves milk production	RE
18/03	Sweden's aXichem Secures Product Registration for Phenylcapsaicin Cattle Feed Additive in Brazil	MT
18/03	Axichem gets product registration in Brazil	RE
10/03	Axichem carries out directed issue of units in connection with completed rights issue	RE
02/03	Axichem announces final outcome of rights issue	RE
27/02	AXichem : announces preliminary outcome of the rights issue	PU
19/02	Axichem Oct-Dec net sales SEK 3.84 million	RE
19/02	AXichem AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
04/02	AXichem carries out rights issue of units of about SEK 11 mln	RE
15/01	AXichem AB Announces Publication of CrossFit Study in Leading Sports Journal - Validates aXivite as a High-Intensity Performance Supplement	CI
08/12	AXichem delivers to Brazil, order worth SEK 7 million	RE
28/11	Axichem Q3 net sales SEK 4.5 million	RE